| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.9M | +24.0% |
| Cost of Revenue | $2.9M | -5.4% |
| R&D Expense | $19.4M | -5.3% |
| SG&A Expense | $32.4M | +40.2% |
| Operating Income | -$38.8M | -14.7% |
| Interest Expense | $2.3M | +186.9% |
| Income Tax | $0 | — |
| Net Income | -$41.0M | -18.6% |
| EPS (Basic) | -$0.67 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.3M | +62.2% |
| Accounts Receivable | $5.0M | +67.8% |
| Current Assets | $99.8M | +62.9% |
| Total Assets | $129.2M | +37.8% |
| Current Liabilities | $8.8M | +20.1% |
| Long-term Debt | $19.9M | +91.0% |
| Total Liabilities | $38.8M | +36.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.6M | +16.0% |
| Capital Expenditures | $592K | +452.1% |
| Investing Cash Flow | -$587K | -447.5% |
| Financing Cash Flow | $65.0M | +146.8% |
| Free Cash Flow | -$29.2M | +14.5% |
| +4.3% |
| EPS (Diluted) | -$0.67 | +4.3% |
| Stockholders' Equity |
| $90.4M |
| +38.5% |